These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34060079)

  • 21. SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Wu Z; Jin Q; Wu G; Lu J; Li M; Guo D; Lan K; Feng L; Qian Z; Ren L; Tan W; Xu W; Yang W; Wang J; Wang C
    Lancet; 2021 Oct; 398(10308):1299-1303. PubMed ID: 34543611
    [No Abstract]   [Full Text] [Related]  

  • 22. How waste water is helping South Africa fight COVID-19.
    Richardson H
    Nature; 2021 May; 593(7860):616-617. PubMed ID: 34031580
    [No Abstract]   [Full Text] [Related]  

  • 23. A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2.
    Gohl DM; Garbe J; Grady P; Daniel J; Watson RHB; Auch B; Nelson A; Yohe S; Beckman KB
    BMC Genomics; 2020 Dec; 21(1):863. PubMed ID: 33276717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany.
    Pfefferle S; Günther T; Kobbe R; Czech-Sioli M; Nörz D; Santer R; Oh J; Kluge S; Oestereich L; Peldschus K; Indenbirken D; Huang J; Grundhoff A; Aepfelbacher M; Knobloch JK; Lütgehetmann M; Fischer N
    Clin Microbiol Infect; 2021 Jan; 27(1):130.e5-130.e8. PubMed ID: 33007476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.
    Tamim S; Trovao NS; Thielen P; Mehoke T; Merritt B; Ikram A; Salman M; Alam MM; Umair M; Badar N; Khurshid A; Mehmood N
    Infect Genet Evol; 2021 Oct; 94():105003. PubMed ID: 34271187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia.
    Gálvez JM; Chaparro-Solano HM; Pinzón-Rondón ÁM; Albornoz LL; Pardo-Oviedo JM; Zapata-Gómez FA; Patiño-Aldana AF; Hernández-Rodríguez ADP; Díaz-Quiroz M; Ruiz-Sternberg ÁM
    Infect Genet Evol; 2022 Jan; 97():105192. PubMed ID: 34933126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Australia: Epidemiology Report 30: Fortnightly reporting period ending 22 November 2020.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33267752
    [No Abstract]   [Full Text] [Related]  

  • 28. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
    Padilla-Rojas C; Jimenez-Vasquez V; Hurtado V; Mestanza O; Molina IS; Barcena L; Morales Ruiz S; Acedo S; Lizarraga W; Bailon H; Cáceres O; Galarza M; Rojas-Serrano N; Vargas-Herrera N; Lope-Pari P; Huayra J; Solari L
    J Med Virol; 2021 Dec; 93(12):6845-6849. PubMed ID: 34370324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.
    Park AK; Rhee JE; Kim IH; Kim HM; Lee H; Kim JA; Lee CY; Lee NJ; Woo S; Lee J; No JS; Rhie GE; Wang SJ; Lee SE; Park YJ; Park G; Kim JY; Gwack J; Yoo CK; Kim EJ
    J Med Virol; 2022 Apr; 94(4):1717-1722. PubMed ID: 34862628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M
    J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient SARS-CoV-2 surveillance strategies to prevent deadly outbreaks in vulnerable populations.
    Toth DJA; Khader K
    BMC Med; 2021 Jan; 19(1):25. PubMed ID: 33478447
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel.
    Addetia A; Lin MJ; Peddu V; Roychoudhury P; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33046529
    [No Abstract]   [Full Text] [Related]  

  • 34. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program.
    Jung A; Droit L; Febles B; Fronick C; Cook L; Handley SA; Parikh BA; Wang D
    Microbiol Spectr; 2024 Aug; 12(8):e0422523. PubMed ID: 38912809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
    Borges V; Isidro J; Cortes-Martins H; Duarte S; Vieira L; Leite R; Gordo I; Caetano CP; Nunes B; Sá R; Oliveira A; Guiomar R; ; Gomes JP
    Emerg Microbes Infect; 2020 Dec; 9(1):2488-2496. PubMed ID: 33131453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Variants in Rhode Island.
    Kantor R; Novitsky V; Carpenter-Azevedo K; Howison M; Manne A; Darpolor JK; Bobenchik A; Tripathi A; Huard RC; King E
    R I Med J (2013); 2021 Sep; 104(7):16-20. PubMed ID: 34279520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance.
    Umair M; Ikram A; Badar N; Haider SA; Rehman Z; Ammar M; Ahad A; Ali Q; Suleman R; Salman M
    J Med Virol; 2022 Jan; 94(1):32-34. PubMed ID: 34499364
    [No Abstract]   [Full Text] [Related]  

  • 39. Want to track pandemic variants faster? Fix the bioinformatics bottleneck.
    Hodcroft EB; De Maio N; Lanfear R; MacCannell DR; Minh BQ; Schmidt HA; Stamatakis A; Goldman N; Dessimoz C
    Nature; 2021 Mar; 591(7848):30-33. PubMed ID: 33649511
    [No Abstract]   [Full Text] [Related]  

  • 40. The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.
    Oude Munnink BB; Worp N; Nieuwenhuijse DF; Sikkema RS; Haagmans B; Fouchier RAM; Koopmans M
    Nat Med; 2021 Sep; 27(9):1518-1524. PubMed ID: 34504335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.